FCH
AMPE

Freestone Capital Holdings’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Freestone Capital Holdings’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3
Closed -$1.59K – 1239
2020
Q4 		$1.59K Hold
3
– – ﹤0.01% 1179
2020
Q3 		$957 Buy
+3
New +$744 ﹤0.01% 1123

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Freestone Capital Holdings's AMPE Position: Q1 2021 in Review

Freestone Capital Holdings sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2021, closing a stake of 3 shares — an estimated $1.59K sold.

Freestone Capital Holdings first reported a position in AMPE in Q3 2020 and held it in 2 quarters. The position peaked at $1.59K in Q4 2020. 110 funds tracked by Wall St. Rank hold AMPE as of Q1 2021.

  • Freestone Capital Holdings reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 3 Ampio Pharmaceuticals Inc. shares in Q1 2021, an estimated $1.59K.
  • Freestone Capital Holdings first reported a position in Ampio Pharmaceuticals Inc. in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's Ampio Pharmaceuticals Inc. position peaked at $1.59K in Q4 2020.
  • 110 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.